Pathologic characteristics of pediatric intracranial pilocytic astrocytomas and their impact on outcome in 3 countries: A multi-institutional study

American Journal of Surgical Pathology

Volumn 36, Issue 1, 2012, Pages 43-55

  Tihan, Tarik ^a   Ersen, Ayca ^a,d   Qaddoumi, Ibrahim ^c   Sughayer, Maher A ^c   Tolunay, Sahsine ^e   Al Hussaini, Maysa ^c   Phillips, Joanna ^a   Gupta, Nalin ^a   Goldhoff, Patricia ^a   Baneerjee, Anu ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KING HUSSEIN CANCER CENTER   (Jordan)

^d DOKUZ EYLUL UNIVERSITY   (Turkey)

^e ULUDAG UNIVERSITY   (Turkey)

Author keywords

astrocytoma; BRAF; pediatric glioma; pilocytic astrocytoma; Sox 2

Indexed keywords

B RAF KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; TUMOR MARKER;

ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CHILD; CLINICAL TRIAL; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; INFANT; KAPLAN MEIER METHOD; MALE; METABOLISM; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; KAPLAN-MEIER ESTIMATE; MALE; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS B-RAF; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84355161678     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182329480     Document Type: Article

References (46)

1. Andrychowski J, Taraszewska A, Czernicki Z, et al. Ten years observation and treatment of multifocal pilocytic astrocytoma. Folia Neuropathol. 2009;47:362-370.
2. Bar EE, Lin A, Tihan T, et al. Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma. J Neuropathol Exp Neurol. 2008;67:878-887.
3. Barr RD. The challenge of childhood cancer in the developing world. East Afr Med J. 1994;71:223-225.
4. Borit A, Richardson EP Jr. The biological and clinical behaviour of pilocytic astrocytomas of the optic pathways. Brain. 1982;105: 161-187. (Pubitemid 12001384)
5. Bouffet E. The 2008 Annual Meeting Of The International Society For Pediatric Neurosurgery: highlights of the oncology session. Expert Rev Neurother. 2009;9:43-45.
6. Bouffet E, Perilongo G, Canete A, et al. Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol. 1998;30:319-329; discussion 329-331.
7. Burkhard C, Di Patre PL, Schuler D, et al. A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma. J Neurosurg. 2003;98:1170-1174. (Pubitemid 36617916)
8. Buschmann U, Gers B, Hildebrandt G. Pilocytic astrocytomas with leptomeningeal dissemination: biological behavior, clinical course, and therapeutical options. Childs Nerv Syst. 2003;19:298-304. (Pubitemid 36869199)
9. Cagnol S, Chambard JC. ERK and cell death: mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence. FEBS J. 2010;277:2-21.
10. Ceppa EP, Bouffet E, Griebel R, et al. The Pilomyxoid astrocytoma and its relationship to pilocytic astrocytoma: report of a case and a critical review of the entity. J Neurooncol. 2007;81:191-196. (Pubitemid 44963978)
11. Chateil JF, Soussotte C, Pedespan JM, et al. MRI and clinical differences between optic pathway tumours in children with and without neurofibromatosis. Br J Radiol. 2001;74:24-31. (Pubitemid 32156627)
12. Cmielova J, Havelek R, Jiroutova A, et al. DNA damage caused by ionizing radiation in embryonic diploid fibroblasts WI-38 induces both apoptosis and senescence. Physiol Res. 2011;60: 667-677.
13. Colosimo C, Cerase A, Maira G. Regression after biopsy of a pilocytic opticochiasmatic astrocytoma in a young adult without neurofibromatosis. Neuroradiology. 2000;42:352-356. (Pubitemid 30265351)
14. Dankort D, Filenova E, Collado M, et al. A new mouse model to explore the initiation, progression, and therapy of brafv600e-induced lung tumors. Genes Dev. 2007;21:379-384.
15. Dankort D, Curley DP, Cartlidge RA, et al. Braf(V600E) cooperates with pten loss to induce metastatic melanoma. Nat Genet. 2009; 41:544-552.
16. Daszkiewicz P, Maryniak A, Roszkowski M, et al. Long-term functional outcome of surgical treatment of juvenile pilocytic astrocytoma of the cerebellum in children. Childs Nerv Syst. 2009; 25:855-860.
17. Erol A. Deciphering the intricate regulatory mechanisms for the cellular choice between cell repair, apoptosis or senescence in response to damaging signals. Cell Signal. 2011;23:1076-1081.
18. Evan GI, d'Adda Di Fagagna F. Cellular senescence: hot or what? Curr Opin Genet Dev. 2009;19:25-31.
19. Fernandez C, Figarella-Branger D, Girard N, et al. Pilocytic astrocytomas in children: prognostic factors-a retrospective study of 80 cases. Neurosurgery. 2003;53:544-553; discussion 554-545.
20. Fisher PG, Tihan T, Goldthwaite PT, et al. Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer. 2008;51:245-250. (Pubitemid 351874420)
21. Forshew T, Tatevossian RG, Lawson AR, et al. Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol. 2009;218:172-181.
22. Frazier JL, Johnson MW, Burger PC, et al. Rapid malignant transformation of low-grade astrocytomas: report of 2 cases and review of the literature. Surg Neurol. 2009;73:53-62.
23. Gajjar A, Sanford RA, Heideman R, et al. Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. J Clin Oncol. 1997;15:2792-2799. (Pubitemid 27330005)
24. Hazin R, Qaddoumi I. Teleoncology: current and future applications for improving cancer care globally. Lancet Oncol. 2010;11: 204-210.
25. Horbinski C, Hamilton RL, Lovell C, et al. Impact of morphology, MIB-1, P53 and MGMT on outcome in pilocytic astrocytomas. Brain Pathol. 2010;20:581-588.
26. Horbinski C, Hamilton RL, Nikiforov Y, et al. Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas. Acta Neuropathol. 2010;119: 641-649.
27. Janisch W, Schreiber D, Martin H, et al. Diencephalic pilocytic astrocytoma with clinical onset in infancy: biological behavior and pathomorphological findings in 11 children. Zentralbl Allg Pathol. 1985;130:31-43. (Pubitemid 15126925)
28. Jones DT, Kocialkowski S, Liu L, et al. Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549: BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. Oncogene. 2009;28:2119-2123.
29. Kestle J, Townsend JJ, Brockmeyer DL, et al. Juvenile pilocytic astrocytoma of the brainstem in children. J Neurosurg. 2004;101: 1-6.
30. Komotar RJ, Burger PC, Carson BS, et al. Pilocytic and pilomyxoid hypothalamic/chiasmatic astrocytomas. Neurosurgery. 2004;54: 72-79; discussion 79-80.
31. Korshunov A, Meyer J, Capper D, et al. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma. Acta Neuropathol. 2009;118:401-405.
32. Louis DN, Ohgaki H, Wiestler OD, et al. Pathology of Tumours of the Central Nervous System. Lyon: IARC Press; 2007.
33. Ma YH, Mentlein R, Knerlich F, et al. Expression of stem cell markers in human astrocytomas of different who grades. Neuroon-col. 2008;86:31-45. (Pubitemid 350263430)
34. Michaloglou C, Vredeveld LC, Soengas MS, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature. 2005;436:720-724. (Pubitemid 41117276)
35. Qaddoumi I, Sultan I, Gajjar A. Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the surveillance, epidemiology, and end results database. Cancer. 2009;115: 5761-5770.
36. Raabe EH, Lim KS, Kim JM, et al. BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model. Clin Cancer Res. 2011;17:3590-3599.
37. Rincheval V, Renaud F, Lemaire C, et al. Bcl-2 can promote p53-dependent senescence versus apoptosis without affecting the G1/S transition. Biochem Biophys Res Commun. 2002;298: 282-288. (Pubitemid 35286340)
38. Rodriguez FJ, Perry A, Gutmann DH, et al. Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients. J Neuropathol Exp Neurol. 2008;67:240-249. (Pubitemid 351483292)
39. Rozen WM, Joseph S, Lo PA. Spontaneous regression of low-grade gliomas in pediatric patients without neurofibromatosis. Pediatr Neurosurg. 2008;44:324-328. (Pubitemid 351931437)
40. Scheithauer BW, Hawkins C, Tihan T, et al. Pilocytic astrocytoma. In: DN L, Ohgaki H, OD W, et al, eds. WHO Classification of Tumours of the Central Nervous System. Lyon: International Agency For Research On Cancer; 2007:14-21.
41. Sharma MK, Watson MA, Lyman M, et al. Matrilin-2 expression distinguishes clinically relevant subsets of pilocytic astrocytoma. Neurology. 2006;66:127-130. (Pubitemid 43739609)
42. Sharma MK, Mansur DB, Reifenberger G, et al. Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. Cancer Res. 2007;67:890-900.
43. Sievert AJ, Jackson EM, Gai X, et al. Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel braf fusion gene. Brain Pathol. 2009;19:449-458.
44. Tihan T, Fisher PG, Kepner JL, et al. Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. J Neuropathol Exp Neurol. 1999;58:1061-1068. (Pubitemid 29468267)
45. Valdueza JM, Lohmann F, Dammann O, et al. Analysis of 20 primarily surgically treated chiasmatic/hypothalamic pilocytic astrocytomas. Acta Neurochir (Wien). 1994;126:44-50. (Pubitemid 24027541)
46. van der wal EJ, Azzarelli B, Edwards-Brown M. Malignant transformation of a chiasmatic pilocytic astrocytoma in a patient with diencephalic syndrome. Pediatr Radiol. 2003;33:207-210. (Pubitemid 36700927)